查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1989045

NeuroCalm技术市场预测至2034年－按产品类型、组件、技术、应用、最终用户、分销管道和地区分類的全球分析

NeuroCalm Tech Market Forecasts to 2034 - Global Analysis By Product Type, Component, Technology, Application, End User, Distribution Channel and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，预计到 2026 年，全球神经镇静技术市场规模将达到 9 亿美元，并在预测期内以 15.7% 的复合年增长率增长，到 2034 年将达到 31 亿美元。

NeuroCalm Tech 指的是一类基于神经科学的设备和数位平台，旨在透过非侵入性干预来监测、调节和改善大脑及心理健康。这些解决方案包括基于脑电图 (EEG) 的头戴式装置、经颅刺激设备、智慧睡眠优化系统以及人工智慧驱动的认知健康应用程序，它们协同工作，帮助解决焦虑症、睡眠障碍、注意力不足过动症 (ADHD) 和创伤后压力症候群 (PTSD) 等问题。透过结合穿戴式硬体、自适应软体和远端医疗服务，NeuroCalm Tech 使个人、临床医生和机构能够以积极主动且个人化的方式提升心理表现和神经系统健康。

人们对心理健康的认识不断提高，推动了心理健康技术的普及。

全球对精神健康障碍及其经济和社会影响的认识不断提高，推动了对技术主导健康解决方案的强劲需求。工作场所压力水平的不断攀升、焦虑和睡眠障碍的盛行率上升，以及人们越来越愿意投资于预防性精神健康工具，都促进了市场的扩张。神经回馈和脑刺激设备在临床和公众中都获得了越来越多的认可，这得益于越来越多的同行评审研究以及主要市场对非侵入性设备的有利法规环境。

高成本阻碍了其在大众市场的渗透。

先进的神经回馈头戴装置、经颅刺激设备及其配套软体平台的高昂价格是阻碍其广泛普及的主要障碍。 NeuroCalm Tech 的许多产品仍属于高端市场，这限制了其用户群体，仅限于对价格敏感的消费者和报销预算有限的医疗机构。此外，消费者神经健康设备缺乏标准化的保险覆盖范围也限制了机构的采购。如果硬体成本无法大幅降低，报销机制不能更清晰，市场渗透率仍将集中在高所得群体和专业临床机构。

与企业健康生态系的整合

企业越来越意识到，认知能力和压力管理是提高员工生产力和留任率的关键因素。企业健康计画的扩展为NeuroCalm Tech供应商提供了一个强大的管道，使其能够实现规模化的B2B分销。基于订阅的神经回馈平台，结合即时心理健康分析仪錶盘，与企业在职业健康和员工留任方面的投入相契合。透过与福利管理机构、职场健康平台和保险公司建立合作关係，NeuroCalm Tech公司能够在大规模员工群体中累积临床证据，同时创造可观的、持续的收入来源。

神经设备监管方面的不确定性

NeuroCalm Tech的产品横跨消费健康设备和临床医疗设备两大类别，这导致其在主要市场面临复杂且不断变化的法规环境。 FDA和CE等监管机构对产品功效声明执行力度不一致，对销售脑部刺激和监控设备的製造商带来合规风险。在相邻类别中，夸大产品功效声明历来会导致监管干预和产品召回。对人工智慧生成的神经学见解日益严格的审查，以及不断演变的生物识别辨识资讯资料隐私法规，进一步加重了製造商在多个司法管辖区的合规负担。

新冠疫情的影响

在全球因封锁、远距办公压力和医疗系统中断而导致心理健康恶化的背景下，新冠疫情显着提升了对NeuroCalm Tech产品的需求。 2020年和2021年，数位健康平台和家用神经回馈设备的普及率出现了显着增长。远端保健的兴起加速了远距神经监测技术融入临床工作流程。疫情后的市场復苏巩固了神经技术作为主流健康领域的地位，消费者和机构对提升心理表现和认知韧性的工具的持续投资，支撑着持续增长且远超市场趋势的需求。

在预测期内，智慧神经回馈头戴装置和穿戴式装置细分市场预计将成为最大的细分市场。

由于智慧神经回馈头戴装置和穿戴式装置在消费者健康、临床治疗和企业绩效管理等广泛应用情境中具有极高的适用性，预计在预测期内，这类装置将占据最大的市场份额。这些设备以可穿戴且非临床的形式提供基于脑电图（EEG）的即时脑活动回馈，使其成为神经反馈技术领域中最易于获取且最具商业性扩充性的产品类型。居家脑力训练的日益普及、消费者对整合正念功能的穿戴式装置的兴趣不断增长，以及透过数位健康零售管道不断扩大的分销管道，都进一步巩固了该细分市场的领先地位。

预计在预测期内，软体和平台领域将实现最高的复合年增长率。

在预测期内，软体和平台细分市场预计将实现最高的复合年增长率，这主要得益于人工智慧驱动的自我调整演算法、基于云端的心理健康监测仪錶板以及用于个性化认知疗法的行动应用生态系统的快速发展。软体平台能够实现持续的远端监测、跨装置的数据聚合以及仅靠硬体无法实现的个人化干预方案。 SaaS订阅模式的扩展、远端保健整合技术的进步以及企业对人工智慧驱动的认知分析平台采购量的增加，正推动该细分市场在整个NeuroCalm Tech市场中实现最快的成长。

市占率最大的地区：

在整个预测期内，北美预计将保持最大的市场份额。这得益于消费者较高的健康意识、完善的数位健康基础设施以及对神经技术Start-Ups的强劲创业投资投资。美国是区域需求的主要驱动力，这得益于其在心理健康诊所、企业健康计划以及开展脑机介面（BCI）临床试验的研究机构中积累的丰富经验。美国食品药物管理局（FDA）对非侵入性神经刺激设备的积极监管态度以及雇主对认知健康提升的不断增长的投资，将进一步巩固北美在整个预测期内的市场主导地位。

复合年增长率最高的地区：

在预测期内，亚太地区预计将呈现最高的复合年增长率，这主要得益于中国、日本、韩国和澳洲都市区心理健康意识的快速提升。政府的心理健康政策、中产阶级可支配收入的增加以及数位健康技术日益融入消费者生活方式，都在加速市场渗透。各地区的电子製造生态系统为具有成本竞争力的硬体开发提供了优势，而远端医疗的日益普及则为面向服务不足人群的人工智慧神经健康平台创建了可扩展的分销管道。

免费客製化服务：

所有购买此报告的客户均可享受以下免费自订选项之一：

  • 企业概况
    • 对其他市场参与者（最多 3 家公司）进行全面分析
    • 对主要企业进行SWOT分析（最多3家公司）
  • 区域细分
    • 应客户要求，我们提供主要国家和地区的市场估算和预测，以及复合年增长率（註：需进行可行性检查）。
  • 竞争性标竿分析
    • 根据产品系列、地理覆盖范围和策略联盟对主要企业进行基准分析。

目录

第一章执行摘要

  • 市场概览及主要亮点
  • 驱动因素、挑战与机会
  • 竞争格局概述
  • 战略洞察与建议

第二章：研究框架

  • 研究目标和范围
  • 相关人员分析
  • 研究假设和限制
  • 调查方法

第三章 市场动态与趋势分析

  • 市场定义与结构
  • 主要市场驱动因素
  • 市场限制与挑战
  • 投资成长机会和重点领域
  • 产业威胁与风险评估
  • 技术与创新展望
  • 新兴市场/高成长市场
  • 监管和政策环境
  • 新冠疫情的影响及復苏前景

第四章：竞争环境与策略评估

  • 波特五力分析
    • 供应商的议价能力
    • 买方的议价能力
    • 替代品的威胁
    • 新进入者的威胁
    • 竞争公司之间的竞争
  • 主要企业市占率分析
  • 产品基准评效和效能比较

第五章 全球NeuroCalm技术市场：依产品类型划分

  • 智慧神经回馈头戴装置和穿戴式装置
  • 经颅刺激器
  • 基于脑电图的脑监测系统
  • 智慧睡眠优化设备
  • 压力和焦虑管理小工具
  • 认知功能改善贴片
  • 神经声学治疗设备

第六章 全球NeuroCalm技术市场：依组件划分

  • 硬体
    • 神经感测器和电极阵列
    • 讯号处理单元
    • 刺激模组
  • 软体平台
    • 自我调整应用程式和行动平台
    • 基于人工智慧的压力分析软体
    • 基于云端的监控仪表板
  • 服务
    • 个人化治疗方案
    • 远端监控和远端医疗服务

第七章 全球NeuroCalm技术市场：依技术划分

  • 脑电图（EEG）
  • 经颅直流电刺激（tDCS）
  • 经颅磁刺激（TMS）
  • 生物回馈疗法与神经回馈技术
  • AI驱动的自我调整演算法
  • 光生物调节（利用光进行神经治疗）
  • 振动声学和声频技术

第八章 全球NeuroCalm技术市场：依应用领域划分

  • 减轻压力和焦虑
  • 睡眠障碍管理
  • 认知功能改善
  • 创伤后压力症候群与创伤康復
  • 注意力不足过动症管理
  • 心理健康与正念

第九章：全球NeuroCalm技术市场：依最终用户划分

  • 一般消费者和注重健康的消费者
  • 医院及精神科医疗机构
  • 企业健康计划
  • 国防和军事组织
  • 体育和运动表现组织
  • 研究和学术机构

第十章 全球NeuroCalm技术市场：按地区划分

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 比利时
    • 瑞典
    • 瑞士
    • 波兰
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 马来西亚
    • 新加坡
    • 越南
    • 其他亚太国家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥伦比亚
    • 智利
    • 秘鲁
    • 其他南美国家
  • 世界其他地区（RoW）
    • 中东
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 卡达
      • 以色列
      • 其他中东国家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲国家

第十一章 策略市场资讯

  • 工业价值网络和供应链评估
  • 空白区域和机会地图
  • 产品演进与市场生命週期分析
  • 通路、经销商和打入市场策略的评估

第十二章 产业趋势与策略倡议

  • 併购
  • 伙伴关係、联盟和合资企业
  • 新产品发布和认证
  • 扩大生产能力和投资
  • 其他策略倡议

第十三章：公司简介

  • Muse（InteraXon Inc.）
  • Emotiv Inc.
  • Neurable Inc.
  • Nuro Diagnostics
  • BrainCo Inc.
  • Flow Neuroscience AB
  • Neurosity Inc.
  • Halo Neuroscience（Halo Sport）
  • BrainsWay Ltd.
  • Cerephex Corporation
  • Thync Global Inc.
  • Kernel（HRL Laboratories, LLC）
  • Medtronic plc
  • Abbott Laboratories
  • Philips Healthcare
  • Garmin Ltd.
  • Natus Medical Incorporated
  • Synchron Inc.
Product Code: SMRC34334

According to Stratistics MRC, the Global NeuroCalm Tech Market is accounted for $0.9 billion in 2026 and is expected to reach $3.1 billion by 2034 growing at a CAGR of 15.7% during the forecast period. NeuroCalm Tech encompasses a category of neuroscience-driven devices and digital platforms designed to monitor, regulate, and improve brain and mental health through non-invasive interventions. These solutions include EEG-based headsets, transcranial stimulation devices, smart sleep optimization systems, and AI-powered cognitive wellness apps that work together to address conditions such as anxiety, sleep disorders, ADHD, and PTSD. By combining wearable hardware with adaptive software and telehealth services, NeuroCalm Tech enables individuals, clinicians, and organizations to take a proactive, personalized approach to mental performance and neurological well-being.

Market Dynamics:

Driver:

Rising Mental Health Awareness Driving Adoption

Growing global awareness of mental health disorders and their economic and social consequences is creating strong demand for technology-driven wellness solutions. Accelerating stress levels in corporate environments, increasing prevalence of anxiety and sleep-related disorders, and growing consumer willingness to invest in preventive mental health tools are collectively expanding the addressable market. Neurofeedback and brain stimulation devices are gaining credibility across clinical and consumer settings alike, supported by a pipeline of peer-reviewed research and favorable regulatory pathways for non-invasive devices in major markets.

Restraint:

High Cost Limiting Mass Market Penetration

The substantial price points associated with advanced neurofeedback headsets, transcranial stimulation devices, and supporting software platforms represent a significant barrier to widespread consumer adoption. Many NeuroCalm Tech products remain positioned in premium segments, limiting access among price-sensitive demographics and healthcare systems with constrained reimbursement budgets. Additionally, the absence of standardized insurance coverage for consumer-grade neuro-wellness devices restricts institutional procurement. Without meaningful reductions in hardware costs and clearer reimbursement frameworks, market penetration will remain concentrated in high-income segments and specialized clinical settings.

Opportunity:

Integration with Corporate Wellness Ecosystems

Enterprises increasingly recognize cognitive performance and stress management as critical components of workforce productivity and retention. The growing adoption of corporate wellness programs presents a compelling channel for NeuroCalm Tech providers to achieve scalable B2B distribution. Subscription-based neurofeedback platforms, combined with real-time mental state analytics dashboards, align with employer investments in occupational health and talent retention. Partnerships with benefits administrators, workplace health platforms, and insurance carriers position NeuroCalm Tech companies to capture significant recurring revenue streams while building clinical evidence bases across large employee cohorts.

Threat:

Regulatory Uncertainty Around Neuro Device Claims

The dual classification challenge for NeuroCalm Tech products, spanning consumer wellness gadgets and clinical medical devices, creates complex and evolving regulatory environments across key markets. Inconsistent enforcement of efficacy claims by agencies such as the FDA and CE regulatory bodies introduces compliance risk for manufacturers marketing brain stimulation and monitoring devices. Overreaching product claims have previously prompted regulatory interventions and product withdrawals in adjacent categories. Heightened scrutiny of AI-generated neurological insights and evolving data privacy regulations for biometric information further elevate the compliance burden across multiple jurisdictions.

Covid-19 Impact

The COVID-19 pandemic significantly elevated demand for NeuroCalm Tech products as global mental health deteriorated amid lockdowns, remote work stress, and healthcare disruption. Digital wellness platforms and at-home neurofeedback devices experienced notable adoption spikes during 2020 and 2021. Telehealth normalization accelerated the integration of remote neuro-monitoring into clinical workflows. Post-pandemic market recovery has reinforced neurotechnology as a mainstream wellness category, with sustained consumer and institutional investment in mental performance and cognitive resilience tools continuing to support above-trend demand trajectories.

The smart neurofeedback headsets and wearables segment is expected to be the largest during the forecast period

The smart neurofeedback headsets and wearables segment is expected to account for the largest market share during the forecast period, owing to its broad applicability across consumer wellness, clinical therapy, and corporate performance management use cases. These devices deliver real-time EEG-based brain activity feedback in a wearable, non-clinical format, making them the most accessible and commercially scalable product category within the NeuroCalm Tech landscape. Rising consumer adoption of at-home brain training, growing interest in mindfulness-integrated wearables, and expanding distribution through digital health retail channels collectively reinforce this segment's dominant market position.

The software and platforms segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the software and platforms segment is expected to register the highest CAGR during the forecast period, driven by rapid advancement in AI-driven neuroadaptive algorithms, cloud-based mental health monitoring dashboards, and mobile application ecosystems for personalized cognitive therapy. Software platforms enable continuous remote monitoring, data aggregation across devices, and personalized intervention programming that hardware alone cannot deliver. Growing SaaS-based subscription models, expanding telehealth integration, and increasing enterprise procurement of AI-powered cognitive analytics platforms are propelling this segment to the fastest growth trajectory across the NeuroCalm Tech market.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, underpinned by high consumer health awareness, well-developed digital health infrastructure, and robust venture capital investment in neurotechnology startups. The United States dominates regional demand, supported by a large installed base of mental health clinics, corporate wellness programs, and research institutions conducting brain-computer interface trials. Favorable FDA regulatory engagement with non-invasive neurostimulation devices and growing employer investment in cognitive health benefits further cement North America's commanding market leadership throughout the forecast period.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by rapidly rising mental health awareness among urban populations in China, Japan, South Korea, and Australia. Government mental health initiatives, expanding middle-class disposable income, and growing integration of digital wellness technologies into consumer lifestyles are accelerating market penetration. Regional electronics manufacturing ecosystems provide cost-competitive hardware development advantages, while increasing telehealth adoption creates scalable distribution channels for AI-powered neuro-wellness platforms across underserved populations.

Key players in the market

Some of the key players in NeuroCalm Tech Market include include Muse (InteraXon Inc.), Emotiv Inc., Neurable Inc., Nuro Diagnostics, BrainCo Inc., Flow Neuroscience AB, Neurosity Inc., Halo Neuroscience (Halo Sport), BrainsWay Ltd., Cerephex Corporation, Thync Global Inc., Kernel (HRL Laboratories, LLC), Medtronic plc, Abbott Laboratories, Philips Healthcare, Garmin Ltd., Natus Medical Incorporated, and Synchron Inc.

Key Developments:

In February 2026, Medtronic plc announced advancements in implantable neurostimulation devices targeting anxiety and mood disorders. These systems combine precision neuromodulation with remote monitoring, strengthening Medtronic's role in digital therapeutics.

In January 2026, Flow Neuroscience AB unveiled a new transcranial direct current stimulation (tDCS) headset for depression management. The innovation integrates app-based tracking, supporting accessible and clinically validated mental health solutions.

In November 2025, Muse (InteraXon Inc.) introduced its next-generation neurofeedback headband with enhanced AI-driven meditation guidance. The device improves stress reduction outcomes and supports personalized mental wellness programs.

Product Types Covered:

  • Smart Neurofeedback Headsets and Wearables
  • Transcranial Stimulation Devices
  • EEG-Based Brain Monitoring Systems
  • Smart Sleep Optimization Devices
  • Stress and Anxiety Management Gadgets
  • Cognitive Enhancement Patches
  • Neuro-Acoustic Therapy Devices

Components Covered:

  • Hardware
  • Software and Platforms
  • Services

Technologies Covered:

  • Electroencephalography (EEG)
  • Transcranial Direct Current Stimulation (tDCS)
  • Transcranial Magnetic Stimulation (TMS)
  • Biofeedback and Neurofeedback Technology
  • AI-Driven Neuroadaptive Algorithms
  • Photobiomodulation (Light-Based Neuro Therapy)
  • Vibro-Acoustic and Sound Frequency Technology

Applications Covered:

  • Stress and Anxiety Reduction
  • Sleep Disorder Management
  • Cognitive Performance Enhancement
  • PTSD and Trauma Recovery
  • ADHD Management
  • Mental Wellness and Mindfulness

End Users Covered:

  • Individual Consumers and Wellness Seekers
  • Hospitals and Psychiatric Centers
  • Corporate Wellness Programs
  • Defense and Military Organizations
  • Sports and Athletic Performance Institutions
  • Research and Academic Institutions

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global NeuroCalm Tech Market, By Product Type

  • 5.1 Smart Neurofeedback Headsets & Wearables
  • 5.2 Transcranial Stimulation Devices
  • 5.3 EEG-Based Brain Monitoring Systems
  • 5.4 Smart Sleep Optimization Devices
  • 5.5 Stress & Anxiety Management Gadgets
  • 5.6 Cognitive Enhancement Patches
  • 5.7 Neuro-Acoustic Therapy Devices

6 Global NeuroCalm Tech Market, By Component

  • 6.1 Hardware
    • 6.1.1 Neuro Sensors & Electrode Arrays
    • 6.1.2 Signal Processing Units
    • 6.1.3 Stimulation Modules
  • 6.2 Software & Platforms
    • 6.2.1 Neuroadaptive Apps & Mobile Platforms
    • 6.2.2 AI-Based Stress Analytics Software
    • 6.2.3 Cloud-Based Monitoring Dashboards
  • 6.3 Services
    • 6.3.1 Personalized Therapy Programs
    • 6.3.2 Remote Monitoring & Telehealth Services

7 Global NeuroCalm Tech Market, By Technology

  • 7.1 Electroencephalography (EEG)
  • 7.2 Transcranial Direct Current Stimulation (tDCS)
  • 7.3 Transcranial Magnetic Stimulation (TMS)
  • 7.4 Biofeedback & Neurofeedback Technology
  • 7.5 AI-Driven Neuroadaptive Algorithms
  • 7.6 Photobiomodulation (Light-Based Neuro Therapy)
  • 7.7 Vibro-Acoustic & Sound Frequency Technology

8 Global NeuroCalm Tech Market, By Application

  • 8.1 Stress & Anxiety Reduction
  • 8.2 Sleep Disorder Management
  • 8.3 Cognitive Performance Enhancement
  • 8.4 PTSD & Trauma Recovery
  • 8.5 ADHD Management
  • 8.6 Mental Wellness & Mindfulness

9 Global NeuroCalm Tech Market, By End User

  • 9.1 Individual Consumers & Wellness Seekers
  • 9.2 Hospitals & Psychiatric Centers
  • 9.3 Corporate Wellness Programs
  • 9.4 Defense & Military Organizations
  • 9.5 Sports & Athletic Performance Institutions
  • 9.6 Research & Academic Institutions

10 Global NeuroCalm Tech Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiles

  • 13.1 Muse (InteraXon Inc.)
  • 13.2 Emotiv Inc.
  • 13.3 Neurable Inc.
  • 13.4 Nuro Diagnostics
  • 13.5 BrainCo Inc.
  • 13.6 Flow Neuroscience AB
  • 13.7 Neurosity Inc.
  • 13.8 Halo Neuroscience (Halo Sport)
  • 13.9 BrainsWay Ltd.
  • 13.10 Cerephex Corporation
  • 13.11 Thync Global Inc.
  • 13.12 Kernel (HRL Laboratories, LLC)
  • 13.13 Medtronic plc
  • 13.14 Abbott Laboratories
  • 13.15 Philips Healthcare
  • 13.16 Garmin Ltd.
  • 13.17 Natus Medical Incorporated
  • 13.18 Synchron Inc.

List of Tables

  • Table 1 Global NeuroCalm Tech Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global NeuroCalm Tech Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global NeuroCalm Tech Market Outlook, By Smart Neurofeedback Headsets & Wearables (2023-2034) ($MN)
  • Table 4 Global NeuroCalm Tech Market Outlook, By Transcranial Stimulation Devices (2023-2034) ($MN)
  • Table 5 Global NeuroCalm Tech Market Outlook, By EEG-Based Brain Monitoring Systems (2023-2034) ($MN)
  • Table 6 Global NeuroCalm Tech Market Outlook, By Smart Sleep Optimization Devices (2023-2034) ($MN)
  • Table 7 Global NeuroCalm Tech Market Outlook, By Stress & Anxiety Management Gadgets (2023-2034) ($MN)
  • Table 8 Global NeuroCalm Tech Market Outlook, By Cognitive Enhancement Patches (2023-2034) ($MN)
  • Table 9 Global NeuroCalm Tech Market Outlook, By Neuro-Acoustic Therapy Devices (2023-2034) ($MN)
  • Table 10 Global NeuroCalm Tech Market Outlook, By Component (2023-2034) ($MN)
  • Table 11 Global NeuroCalm Tech Market Outlook, By Hardware (2023-2034) ($MN)
  • Table 12 Global NeuroCalm Tech Market Outlook, By Neuro Sensors & Electrode Arrays (2023-2034) ($MN)
  • Table 13 Global NeuroCalm Tech Market Outlook, By Signal Processing Units (2023-2034) ($MN)
  • Table 14 Global NeuroCalm Tech Market Outlook, By Stimulation Modules (2023-2034) ($MN)
  • Table 15 Global NeuroCalm Tech Market Outlook, By Software & Platforms (2023-2034) ($MN)
  • Table 16 Global NeuroCalm Tech Market Outlook, By Neuroadaptive Apps & Mobile Platforms (2023-2034) ($MN)
  • Table 17 Global NeuroCalm Tech Market Outlook, By AI-Based Stress Analytics Software (2023-2034) ($MN)
  • Table 18 Global NeuroCalm Tech Market Outlook, By Cloud-Based Monitoring Dashboards (2023-2034) ($MN)
  • Table 19 Global NeuroCalm Tech Market Outlook, By Services (2023-2034) ($MN)
  • Table 20 Global NeuroCalm Tech Market Outlook, By Personalized Therapy Programs (2023-2034) ($MN)
  • Table 21 Global NeuroCalm Tech Market Outlook, By Remote Monitoring & Telehealth Services (2023-2034) ($MN)
  • Table 22 Global NeuroCalm Tech Market Outlook, By Technology (2023-2034) ($MN)
  • Table 23 Global NeuroCalm Tech Market Outlook, By Electroencephalography (EEG) (2023-2034) ($MN)
  • Table 24 Global NeuroCalm Tech Market Outlook, By Transcranial Direct Current Stimulation (tDCS) (2023-2034) ($MN)
  • Table 25 Global NeuroCalm Tech Market Outlook, By Transcranial Magnetic Stimulation (TMS) (2023-2034) ($MN)
  • Table 26 Global NeuroCalm Tech Market Outlook, By Biofeedback & Neurofeedback Technology (2023-2034) ($MN)
  • Table 27 Global NeuroCalm Tech Market Outlook, By AI-Driven Neuroadaptive Algorithms (2023-2034) ($MN)
  • Table 28 Global NeuroCalm Tech Market Outlook, By Photobiomodulation (Light-Based Neuro Therapy) (2023-2034) ($MN)
  • Table 29 Global NeuroCalm Tech Market Outlook, By Vibro-Acoustic & Sound Frequency Technology (2023-2034) ($MN)
  • Table 30 Global NeuroCalm Tech Market Outlook, By Application (2023-2034) ($MN)
  • Table 31 Global NeuroCalm Tech Market Outlook, By Stress & Anxiety Reduction (2023-2034) ($MN)
  • Table 32 Global NeuroCalm Tech Market Outlook, By Sleep Disorder Management (2023-2034) ($MN)
  • Table 33 Global NeuroCalm Tech Market Outlook, By Cognitive Performance Enhancement (2023-2034) ($MN)
  • Table 34 Global NeuroCalm Tech Market Outlook, By PTSD & Trauma Recovery (2023-2034) ($MN)
  • Table 35 Global NeuroCalm Tech Market Outlook, By ADHD Management (2023-2034) ($MN)
  • Table 36 Global NeuroCalm Tech Market Outlook, By Mental Wellness & Mindfulness (2023-2034) ($MN)
  • Table 37 Global NeuroCalm Tech Market Outlook, By End User (2023-2034) ($MN)
  • Table 38 Global NeuroCalm Tech Market Outlook, By Individual Consumers & Wellness Seekers (2023-2034) ($MN)
  • Table 39 Global NeuroCalm Tech Market Outlook, By Hospitals & Psychiatric Centers (2023-2034) ($MN)
  • Table 40 Global NeuroCalm Tech Market Outlook, By Corporate Wellness Programs (2023-2034) ($MN)
  • Table 41 Global NeuroCalm Tech Market Outlook, By Defense & Military Organizations (2023-2034) ($MN)
  • Table 42 Global NeuroCalm Tech Market Outlook, By Sports & Athletic Performance Institutions (2023-2034) ($MN)
  • Table 43 Global NeuroCalm Tech Market Outlook, By Research & Academic Institutions (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.